iData Insights

Relmada Therapeutics, Inc. - Product Pipeline Review – 2015 Now Available at iData Insights

News   •   Dec 01, 2015 12:01 IST

provides an overview of the Relmada Therapeutics, Inc. s pharmaceutical research and development focus.

This report provides comprehensive information on the current therapeutic developmental pipeline of Relmada Therapeutics, Inc. s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects. Global Markets Direct s report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct s proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct s team.

Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis. The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products. Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease. Scope - The report provides brief overview of Relmada Therapeutics, Inc. including business description, key information and facts, and its locations and subsidiaries - The report reviews current pipeline of Relmada Therapeutics, Inc. s human therapeutic division and enlists all their major and minor projects - The report features product description and descriptive mechanism of action for key pipeline products along with the product s developmental history and major milestones - Special feature on out-licensed and partnered product portfolio - The report summarizes all the dormant and discontinued pipeline projects - Latest company statement - Latest news and deals relating to the Relmada Therapeutics, Inc. s pipeline products Reasons to buy - Evaluate Relmada Therapeutics, Inc.

strategic position with total access to detailed information on its product pipeline - Assess the growth potential of Relmada Therapeutics, Inc. in its therapy areas of focus - Identify new drug targets and therapeutic classes in the Relmada Therapeutics, Inc. s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas - Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps - Develop strategic initiatives by understanding the focus areas of Relmada Therapeutics, Inc. and exploit collaboration and partnership opportunities - Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage - Plan mergers and acquisitions effectively by identifying the most promising pipeline of Relmada Therapeutics, Inc. - Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope - Explore the dormant and discontinued projects of Relmada Therapeutics, Inc. and identify potential opportunities in those areas - Avoid Intellectual Property Rights related issues

Browse Complete Report with TOC @http://www.idatainsights.com/reports-landing-page.php?id=124230/brain-cancer-pipeline-review-h2-2015

To Get Sample Copy of Report visit @http://www.idatainsights.com/reports-landing-page.php?id=124230/brain-cancer-pipeline-review-h2-2015

Table of Contents

Table of Contents 2

List of Tables 4

List of Figures 4

Relmada Therapeutics, Inc. Snapshot 5

Relmada Therapeutics, Inc. Overview 5

Key Information 5

Key Facts 5

Relmada Therapeutics, Inc. - Research and Development Overview 6

Key Therapeutic Areas 6

Relmada Therapeutics, Inc. - Pipeline Review 8

Pipeline Products by Stage of Development 8

Pipeline Products - Monotherapy 9

Relmada Therapeutics, Inc. - Pipeline Products Glance 10

Relmada Therapeutics, Inc. - Clinical Stage Pipeline Products 10

Phase II Products/Combination Treatment Modalities 10

Phase I Products/Combination Treatment Modalities 11

Relmada Therapeutics, Inc. - Early Stage Pipeline Products 12

Preclinical Products/Combination Treatment Modalities 12

Relmada Therapeutics, Inc. - Drug Profiles 13

levorphanol tartrate ER 13

Product Description 13

Mechanism of Action 13

R&D Progress 13

buprenorphine hydrochloride ER 15

Product Description 15

Mechanism of Action 15

R&D Progress 15

REL-1017 16

Product Description 16

Mechanism of Action 16

R&D Progress 16

mepivacaine hydrochloride 17

Product Description 17

Mechanism of Action 17

R&D Progress 17

Relmada Therapeutics, Inc. - Pipeline Analysis 18

Relmada Therapeutics, Inc. - Pipeline Products by Target 18

Relmada Therapeutics, Inc. - Pipeline Products by Route of Administration 19

Relmada Therapeutics, Inc. - Pipeline Products by Molecule Type 20

Relmada Therapeutics, Inc. - Pipeline Products by Mechanism of Action 21

Relmada Therapeutics, Inc. - Recent Pipeline Updates 22

Relmada Therapeutics, Inc. - Dormant Projects 26

Relmada Therapeutics, Inc. - Locations And Subsidiaries 27

Head Office 27

Appendix 28

Methodology 28

Coverage 28

Secondary Research 28

Primary Research 28

Expert Panel Validation 28

Contact Us 28

Disclaimer 29

Read More http://www.idatainsights.com/reports-landing-page.php?id=124230/brain-cancer-pipeline-review-h2-2015

About Us:

iData Insights which operates under Precision Research and Consulting Private Limited is a leading market research information aggregator and marketing research consulting firm. We conduct both primary and secondary research. Our work does not end with research it is also involved in distributing reports for different companies . We provide actionable recommendations and provide our expertise for business success today and tomorrow. It is our goal to be a partner to our clients in the exploration and discovery, and then be their guide in the implementation of changes that will make a difference to their bottom line.

ContactUs:
iData Insights

Tel: 1-866-237-2965

Web: http://www.idatainsights.com
Email: info@idatainsights.com

AboutiData Insights

We work around the clock until our clients are completely satisfied with their promised results. It is our mission to provide timely services coupled with acute client care to create a long-lasting relationship with you. We deliver on our promise to provide results that are essential to the success of your company. We believe that by doing so, we will earn the trust of our clients for future projects